Literature DB >> 26294722

Over 50 Years of Fibrinogen Concentrate.

Rubens Costa-Filho1, Gerald Hochleitner2, Michael Wendt3, Alexandre Teruya4, Donat R Spahn5.   

Abstract

March 2013 represented the 50th anniversary of the first license granted for a fibrinogen concentrate. In this review, we look at the history of bleeding management that led to the development of fibrinogen concentrate, discuss its current use, and consider future developments for this product.
© The Author(s) 2015.

Entities:  

Keywords:  bleeding; blood coagulation factors; hemostasis

Mesh：

Substances：

Year:  2015        PMID： 26294722      PMCID： PMC4741261          DOI： 10.1177/1076029615601494

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN： 1076-0296            Impact factor:   2.389


  51 in total

1.  The history of blood transfusion.

Authors:  P L Giangrande
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

2.  Forgotten transfusion history: John Leacock of Barbados.

Authors:  P J Schmidt; A G Leacock
Journal:  BMJ       Date:  2002-12-21

Review 3.  The role of fibrinogen and haemostatic assessment in postpartum haemorrhage: preparations for a randomised controlled trial.

Authors:  Anne Juul Wikkelsø
Journal:  Dan Med J       Date:  2015-04       Impact factor: 1.240

4.  Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial.

Authors:  Filomena R B G Galas; Juliano P de Almeida; Júlia T Fukushima; Jean Louis Vincent; Eduardo A Osawa; Suely Zeferino; Lígia Câmara; Vanessa A Guimarães; Marcelo B Jatene; Ludhmila A Hajjar
Journal:  J Thorac Cardiovasc Surg       Date:  2014-04-18       Impact factor: 5.209

5.  Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial.

Authors:  A J Wikkelsø; H M Edwards; A Afshari; J Stensballe; J Langhoff-Roos; C Albrechtsen; K Ekelund; G Hanke; E L Secher; H F Sharif; L M Pedersen; A Troelstrup; J Lauenborg; A U Mitchell; L Fuhrmann; J Svare; M G Madsen; B Bødker; A M Møller
Journal:  Br J Anaesth       Date:  2015-01-13       Impact factor: 9.166

Review 6.  Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data.

Authors:  C Solomon; A Gröner; J Ye; I Pendrak
Journal:  Thromb Haemost       Date:  2014-12-11       Impact factor: 5.249

7.  Coagulation management with factor concentrates in liver transplantation: a single-center experience.

Authors:  Carmen Kirchner; Daniel Dirkmann; Jürgen W Treckmann; Andreas Paul; Matthias Hartmann; Fuat H Saner; Klaus Görlinger
Journal:  Transfusion       Date:  2014-05-14       Impact factor: 3.157

8.  The effect of fibrinogen concentrate administration on coagulation abnormalities in a rat sepsis model.

Authors:  Franz Kaspereit; Baerbel Doerr; Gerhard Dickneite
Journal:  Blood Coagul Fibrinolysis       Date:  2004-01       Impact factor: 1.276

Review 9.  Fibrinogen--marker or mediator of vascular disease?

Authors:  Walter H Reinhart
Journal:  Vasc Med       Date:  2003       Impact factor: 3.239

10.  Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.

Authors:  Marco Ranucci; Ekaterina Baryshnikova; Giulia Beatrice Crapelli; Niels Rahe-Meyer; Lorenzo Menicanti; Alessandro Frigiola
Journal:  J Am Heart Assoc       Date:  2015-06-02       Impact factor: 5.501
View more
  8 in total

1.  Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy.

Authors:  N Rahe-Meyer; J H Levy; C D Mazer; A Schramko; A A Klein; R Brat; Y Okita; Y Ueda; D S Schmidt; R Ranganath; R Gill
Journal:  Br J Anaesth       Date:  2016-07       Impact factor: 9.166

2.  Ticks elicit variable fibrinogenolytic activities upon feeding on hosts with different immune backgrounds.

Authors:  Ashish Vora; Vikas Taank; Sucharita M Dutta; John F Anderson; Durland Fish; Daniel E Sonenshine; John D Catravas; Hameeda Sultana; Girish Neelakanta
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

Review 3.  Acquired hypofibrinogenemia: current perspectives.

Authors:  Martin W Besser; Stephen G MacDonald
Journal:  J Blood Med       Date:  2016-09-26

4.  Evaluating the Tactical Combat Casualty Care principles in civilian and military settings: systematic review, knowledge gap analysis and recommendations for future research.

Authors:  Rachel Strauss; Isabella Menchetti; Laure Perrier; Erik Blondal; Henry Peng; Wendy Sullivan-Kwantes; Homer Tien; Avery Nathens; Andrew Beckett; Jeannie Callum; Luis Teodoro da Luz
Journal:  Trauma Surg Acute Care Open       Date:  2021-10-19

Review 5.  Pathophysiology of Coagulation and Emerging Roles for Extracellular Vesicles in Coagulation Cascades and Disorders.

Authors:  Houssam Al-Koussa; Ibrahim AlZaim; Marwan E El-Sabban
Journal:  J Clin Med       Date:  2022-08-22       Impact factor: 4.964

Review 6.  Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease.

Authors:  Prajeeda M Nair; Matthew J Rendo; Kristin M Reddoch-Cardenas; Jason K Burris; Michael A Meledeo; Andrew P Cap
Journal:  Semin Hematol       Date:  2020-07-27       Impact factor: 3.851

7.  A Low-dose human fibrinogen is not effective in decreasing postoperative bleeding and transfusion requirements during cardiac surgery in case of concomitant clinical bleeding and low FIBTEM values: A retrospective matched study.

Authors:  Iuliana-Marinela Lupu; Zineb Rebaine; Laurence Lhotel; Christine Watremez; Stéphane Eeckhoudt; Michel Van Dyck; Mona Momeni
Journal:  Ann Card Anaesth       Date:  2018 Jul-Sep

8.  [How I use fibrinogen replacement treatment in acquired bleeding].

Authors:  H Mei; Y Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-10-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.